BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koliakos, G G
Right arrow Articles by Ritch, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koliakos, G G
Right arrow Articles by Ritch, R
British Journal of Ophthalmology 2003;87:353-356
© 2003 BMJ Publishing Group


LABORATORY SCIENCE

8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome

G G Koliakos1, A G P Konstas2, U Schlötzer-Schrehardt3, G Hollo4, I E Katsimbris5, N Georgiadis2, R Ritch6

1 Department of Biological Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
2 University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
3 Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany
4 1st Department of Ophthalmology, Semmelweis University, Budapest, Hungary
5 Department of Ophthalmology, General Hospital of Patra, Patra, Greece
6 Glaucoma Service, Department of Ophthalmology, The New York Eye and Ear Infirmary, New York City, USA

Correspondence to:
Correspondence to:
G Koliakos, MD, PhD, PO Box 17034, 54210 Thessaloniki, Greece;
koliakos{at}med.auth.gr

Background/aim: The authors investigated the concentrations of 8-isoprostaglandin F2a, a marker of oxidative stress in vivo, and ascorbic acid, a protectant against oxidative damage, in the aqueous humour of patients with exfoliation syndrome (XFS) and cataract and compared the results with those in age matched patients with cataract, but without XFS, to determine whether XFS is associated with increased oxidative stress.

Methods: Aqueous humour was aspirated at the beginning of phacoemulsification cataract surgery from 27 eyes of 27 cataract patients with XFS and 27 eyes of 27 age matched cataract patients without XFS. 8-Isoprostaglandin F2aconcentration in the aqueous was determined with a commercial immunoassay; ascorbic acid concentration was measured with a microplate assay method.

Results:. The mean concentration of 8-isoprostaglandin F2ain the aqueous from patients with XFS (2429 (SD 2940) pg/ml; range 400–10500 pg/ml) was significantly higher than that measured in the aqueous of age matched control patients (529.1 (226.8) pg/ml; range 325–1000 pg/ml); (p = 0.0028). Furthermore, mean ascorbic acid concentration in XFS patients (0.75 (0.39) mM; range 0.28–1.70 mM) was significantly lower than that found in control patients (1.19 (0.47) mM; range 0.53–2.4 mM); (p = 0.0005). There was a reverse correlation between 8-isoprostaglandin F2aand ascorbic acid concentration.

Conclusion: 8-Isoprostaglandin F2awas significantly increased in the aqueous of patients with XFS, and ascorbic acid was decreased, providing evidence of a role for free radical induced oxidative damage in the pathobiology of XFS.





This article has been cited by other articles:


Home page
IOVSHome page
M. Zenkel, F. E. Kruse, G. O. H. Naumann, and U. Schlotzer-Schrehardt
Impaired Cytoprotective Mechanisms in Eyes with Pseudoexfoliation Syndrome/Glaucoma
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5558 - 5566.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Zenkel, F. E. Kruse, A. G. Junemann, G. O. H. Naumann, and U. Schlotzer-Schrehardt
Clusterin Deficiency in Eyes with Pseudoexfoliation Syndrome May Be Implicated in the Aggregation and Deposition of Pseudoexfoliative Material
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1982 - 1990.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Zenkel, E. Poschl, K. von der Mark, C. Hofmann-Rummelt, G. O. H. Naumann, F. E. Kruse, and U. Schlotzer-Schrehardt
Differential Gene Expression in Pseudoexfoliation Syndrome
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3742 - 3752.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Wang, H. Zhu, H. Sun, J. Pan, Z. Yuan, and R. Yu
Plasma 8-Isoprostane Concentrations in Patients with Age-Related Cataracts
Clin. Chem., August 1, 2005; 51(8): 1541 - 1544.
[Full Text] [PDF]


Home page
IOVSHome page
U. Schlotzer-Schrehardt, M. Zenkel, U. Decking, D. Haubs, F. E. Kruse, A. Junemann, M. Coca-Prados, and G. O. H. Naumann
Selective Upregulation of the A3 Adenosine Receptor in Eyes with Pseudoexfoliation Syndrome and Glaucoma
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2023 - 2034.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S L Ho, G F Dogar, J Wang, J Crean, Q D Wu, N Oliver, S Weitz, A Murray, P E Cleary, and C O'Brien
Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome
Br. J. Ophthalmol., February 1, 2005; 89(2): 169 - 173.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
G G Koliakos, A G P Konstas, U Schlotzer-Schrehardt, G Hollo, D Mitova, D Kovatchev, S Maloutas, and N Georgiadis
Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome
Br. J. Ophthalmol., April 1, 2004; 88(4): 523 - 527.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A L Young, W W T Tang, and D S C Lam
The prevalence of pseudoexfoliation syndrome in Chinese people
Br. J. Ophthalmol., February 1, 2004; 88(2): 193 - 195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.